Integrate robust QC at critical points in your CRISPR workflow. Get data to predict editing efficiency and optimize conditions for successful biologics production.
CDMOs and CROs use functional CRISPR QC assays to identify Cas enzymes with the highest cleavage activity, pre-screen starting materials, verify lot-to-lot performance, and predict editing efficiencies before costly production runs.
Increase confidence in biomanufacturing timelines with in vitro functional assays that complement—and often precede—cell-based confirmation.
Compare Cas and gRNA lots with quantitative functional readouts.
Align QC checkpoints with the decisions that matter for scale-up.
Explore other workflow challenges: RNP Formation · DNA Target Binding · CLEAVE · Technology
